Press release
23.05.2025 To the attention of interested persons EMA starts review of ipidacrine-containing medicines download document …
23.05.2025 To the attention of interested persons EMA starts review of ipidacrine-containing medicines download document …
08.05.2025 To the attention of interested persons Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines download […]
07.05.2025 To the attention of interested persons EMA starts review of Ixchiq (live attenuated chikungunya vaccine) download document …
13.03.2025 To the attention of interested persons Unregulated advanced therapy medicinal products pose serious risks to health download document …
17.01.2025 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025 download […]
13.12.2024 To the attention of interested persons Alofisel withdrawn from the EU market download document …
09.12.2024 To the attention of interested persons ETF statement on the loss of activity of anti-spike protein monoclonal antibodies due […]
29.11.2024 To the attention of interested persons Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 November 2024 download […]
15.11.2024 To the attention of interested persons Updated advice to minimise risks of interaction between weight loss medicine Mysimba and […]
14.11.2024 To the attention of interested persons Leqembi recommended for treatment of early Alzheimer’s disease download document …